CNS Pharmaceuticals, Inc

The annual 10-K, the quarterly 10-Q and the 8-K filed between them when something material happens.

1. Oct 28-KOfficer or director change and shareholder vote5.025.079.01
2. Aug 1210-QQuarterly report
3. Jul 28-KRegulation FD disclosure7.019.01
4. May 26424B3Prospectus for an offering
5. May 19S-3Shelf registration
6. May 1410-QQuarterly report
7. May 48-KMaterial agreement and unregistered sale of shares1.013.025.029.01
8. Mar 3110-KAnnual report
9. Mar 118-KRegulation FD disclosure7.019.01
10. Mar 28-KOfficer or director change5.029.01
11. Feb 178-KOfficer or director change5.029.01
12. Dec 17, 20258-KOfficer or director change5.029.01
13. Nov 21, 20258-KOfficer or director change and bylaws or fiscal year changed5.025.035.079.01
14. Nov 14, 202510-QQuarterly report
15. Sep 19, 2025424B5Prospectus for an offering
16. Aug 14, 202510-QQuarterly report
17. Jul 22, 20258-KBylaws or fiscal year changed and other events3.035.038.019.01
18. Jul 15, 20258-KRegulation FD disclosure7.019.01
19. May 15, 202510-QQuarterly report
20. May 14, 20258-KMaterial agreement1.019.01
21. May 14, 2025424B4Prospectus for an offering
22. Apr 14, 2025S-1Registration of new shares
23. Apr 9, 20258-KRegulation FD disclosure7.019.01
24. Mar 31, 20258-KOther events8.01
25. Mar 31, 202510-KAnnual report
26. Mar 20, 2025424B5Prospectus for an offering
27. Mar 20, 20258-KOther events8.019.01
28. Feb 21, 20258-KOther events and change to shareholder rights3.038.019.01
29. Jan 3, 20258-KRegulation FD disclosure and other events7.018.019.01
30. Dec 11, 20248-KRegulation FD disclosure7.019.01
31. Dec 3, 20248-KShareholder vote5.07
32. Nov 14, 202410-QQuarterly report
33. Nov 1, 20248-KOther events8.01
34. Oct 24, 20248-KMaterial agreement and other events1.018.019.01
35. Oct 24, 2024424B5Prospectus for an offering
36. Oct 23, 20248-KOther events8.01